Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPGG 0.25% vs Vehicle in Dry Eye
NCT00840268Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2009
- Primary completion
- Jul 2009
- Modality
- Polymer-based Nanoparticles
01
Overview
A Phase 2 trial of hydroxypropyl-guar in dry eye syndrome (DED), sponsored by Alcon Inc.. Started Feb 2009; status: completed.
02
Drugs
hydroxypropyl-guar
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00840268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840268.